December 2-5, 2024 | Fort Lauderdale, Florida
Philadelphia, December 2, 2024 – XCMR today announced its participation in the 2024 Chemical and Biological Defense Science & Technology (CBD S&T) Conference. This major event brings together global innovators, researchers, and experts to address future chem-bio threats.
Members of the chemical and biological defense community will be in attendance at the event, sponsored by the Defense Threat Reduction Agency’s (DTRA) Chemical and Biological Technologies Department. This department serves as the Joint Science and Technology Office (JSTO) for the Chemical and Biological Defense Program. Eric Prast, VP of Product Engineering at XCMR will be presenting a poster under the topic of Science and Technology Advances for Chemical and Biological Protection titled Far-UVC based approaches to mitigating wound and surgical site bioburden.
The 2024 Chemical and Biological Defense Science & Technology (CBD S&T) Conference, one of the largest chem-bio defense science and technology conferences in recent years, brought together innovators, researchers, and experts from around the globe, fostering the exchange of insights and collaborative ideations on the pressing chem-bio threats of tomorrow.
Over 1,700 chemical and biological defense community members joined the DTRA Chemical and Biological Technologies Department in its role as the JSTO for the Chemical and Biological Defense Program and explored transformative, change-making concepts in the chem-bio defense landscape. Key focus areas were CBD S&T’s mission to protect the joint force and the nation through transformational solutions in chem-bio defense science and technology including: approaches to characterizing the threat from chemical and biological (CB) agents, innovations to make hard decisions easier – generating actionable information in the digital battlespace, developing medical countermeasures against chemical threats, mitigating CB hazards for Joint Forces and mission, envisioning the future of CB detection and diagnostics, protecting the Joint Forces from CB threats, and medical countermeasures.
XCMR leads in biosecurity innovation incorporating UV-C into wearable, portable and stationary devices to prevent the transmission of infectious disease. XCMR’s IoT cloud enables AI-driven predictive analytics to improve visibility, response and preparedness for scaled infection transmission resiliency.
Breakthrough achievements. Based on science and research. Powered by a passion to improve health security for all.
